0
Article Tier 2 Sign in to save

Percutaneous coronary intervention leads to microplastics entering the blood: Interventional devices are a major source

Journal of Hazardous Materials 2024 30 citations

AI summary Read the abstract

Researchers measured microplastic levels in the blood of 23 patients before and after heart stent procedures (percutaneous coronary intervention) and found that microplastic concentrations jumped nearly 19-fold after the procedure. The types of plastics found in the blood matched those detected on the medical devices used during the procedure, confirming that the devices themselves were the source. This study reveals that common medical procedures using plastic equipment may be an overlooked route for microplastics to enter the human bloodstream.

Microplastics (MPs) is an emerging pollutant potentially harmful to health. Medical practices using plastic devices, such as percutaneous coronary interventions (PCI), may result in MPs entering into the blood. The purpose of this study was to quantify the effect of PCI on microplastic levels in patients' blood. Laser direct infrared (LDIR) was used to detect MPs in the blood of 23 patients before and after PCI. MPs in the water in which devices used in PCI were washed were also examined. The concentration of MPs in the blood was significantly elevated (93.57 ± 35.95 vs. 4.96 ± 3.40 particles/10 mL of blood, P < 0.001) after PCI compared to before, and the increased MPs were polyamide (PA), polyethylene (PE), polyurethane (PU), and polyethylene terephthalate (PET), which was consistent with the types of MPs detected in the device washing water. The maximum diameter of MPs in blood before PCI was 50 µm, whereas after PCI it was 213 µm, and even 336 µm in device washing water. These findings indicated that PCI will cause MPs to enter the blood, and devices used during PCI were a major source, a range of medical practices that use plastic devices may be a new route for MPs to enter the human body.

More Papers Like This

Article Tier 2

Microplastic entry into bloodstream via hemodialysis: A dual-simulation clinical study

AI summary Read the abstract

Researchers measured microplastics in the blood of nine patients before and after hemodialysis, finding that particle counts nearly doubled post-procedure, with polymer types matching dialysis tubing materials — suggesting medical plastic devices are a direct route of microplastic entry into the bloodstream.

Article Tier 2

Microplastics in cardiopulmonary bypass: quantification and characterization of particles across systems

AI summary Read the abstract

Researchers measured microplastic contamination generated by cardiopulmonary bypass machines used during heart surgery and found significant levels of plastic particles across the systems tested. The study characterized the types and quantities of microplastics produced during machine operation. The findings raise questions about patient exposure to microplastics during cardiac procedures and highlight the need for further research into whether these particles have clinical significance.

Article Tier 2

Microplastics release from coronary catheters: Insights from catheter analysis

AI summary Read the abstract

This study examined whether cardiac catheters used in heart procedures release microplastic particles, and found that all 21 catheter samples tested shed microplastics of varying sizes and types. The findings raise important questions about patient safety, since these tiny plastic fragments could enter the bloodstream during routine cardiovascular procedures.

Article Tier 2

Characteristics and influencing factors of microplastics entering human blood through intravenous injection

AI summary Read the abstract

This study found that common medical devices used for intravenous injections -- syringes, infusion sets, and vein needles -- release microplastics directly into patients' bloodstreams. The dominant particles were polyethylene and polypropylene fragments, and repeated use of devices significantly increased the amount released. While the total number of particles entering the body this way is lower than from food, the direct injection into blood makes this exposure pathway especially concerning.

Article Tier 2

Microplastics and nanoplastics increase major adverse cardiac events in patients with myocardial infarction

AI summary Read the abstract

In a study of 142 heart attack patients, researchers found microplastics and nanoplastics in the coronary blood of nearly all participants, with polyvinyl chloride (PVC) detected in over 95% of samples. Higher PVC levels were linked to increased inflammatory markers and a significantly greater risk of major heart complications over the 31.5-month follow-up period. For every 10-unit increase in PVC concentration, the risk of a major cardiac event more than doubled.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper